These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 28276567)

  • 1. Patient values and preferences for antithrombotic therapy in atrial fibrillation. A Narrative Systematic Review.
    Loewen PS; Ji AT; Kapanen A; McClean A
    Thromb Haemost; 2017 Jun; 117(6):1007-1022. PubMed ID: 28276567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Web-based education resources informing patients about stroke prevention in atrial fibrillation.
    Pandya E; Bajorek BV
    J Clin Pharm Ther; 2016 Dec; 41(6):667-676. PubMed ID: 27704588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physician and Patient Preferences for Nonvalvular Atrial Fibrillation Therapies.
    Shafrin J; Bruno A; MacEwan JP; Campinha-Bacote A; Trocio J; Shah M; Tan W; Romley JA
    Value Health; 2016 Jun; 19(4):451-9. PubMed ID: 27325337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lessons from the Stroke Prevention in Atrial Fibrillation trials.
    Hart RG; Halperin JL; Pearce LA; Anderson DC; Kronmal RA; McBride R; Nasco E; Sherman DG; Talbert RL; Marler JR;
    Ann Intern Med; 2003 May; 138(10):831-8. PubMed ID: 12755555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decision-making around antithrombotics for stroke prevention in atrial fibrillation: the health professionals' views.
    Wang Y; Bajorek B
    Int J Clin Pharm; 2016 Aug; 38(4):985-95. PubMed ID: 27286973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of patients' attitudes towards stroke prevention and bleeding risk in atrial fibrillation.
    Lahaye S; Regpala S; Lacombe S; Sharma M; Gibbens S; Ball D; Francis K
    Thromb Haemost; 2014 Mar; 111(3):465-73. PubMed ID: 24337399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.
    Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP
    Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) Phase I cohort.
    Huisman MV; Ma CS; Diener HC; Dubner SJ; Halperin JL; Rothman KJ; Teutsch C; Schoof N; Kleine E; Bartels DB; Lip GY;
    Europace; 2016 Sep; 18(9):1308-18. PubMed ID: 27335063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and rationale of Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation: a global registry program on long-term oral antithrombotic treatment in patients with atrial fibrillation.
    Huisman MV; Lip GY; Diener HC; Dubner SJ; Halperin JL; Ma CS; Rothman KJ; Teutsch C; Zint K; Ackermann D; Clemens A; Bartels DB
    Am Heart J; 2014 Mar; 167(3):329-34. PubMed ID: 24576516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antithrombotic therapy in patients with first-ever stroke and known non-rheumatic atrial fibrillation].
    Gandjour J; Zeindler J; Georgiadis D; Baumgartner RW
    Praxis (Bern 1994); 2005 Jan; 94(4):97-104. PubMed ID: 15732803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Residential medication management reviews of antithrombotic therapy in aged care residents with atrial fibrillation: assessment of stroke and bleeding risk.
    Nishtala PS; Castelino RL; Peterson GM; Hannan PJ; Salahudeen MS
    J Clin Pharm Ther; 2016 Jun; 41(3):279-84. PubMed ID: 27062272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Singer DE; Albers GW; Dalen JE; Go AS; Halperin JL; Manning WJ
    Chest; 2004 Sep; 126(3 Suppl):429S-456S. PubMed ID: 15383480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A patient decision aid regarding antithrombotic therapy for stroke prevention in atrial fibrillation: a randomized controlled trial.
    Man-Son-Hing M; Laupacis A; O'Connor AM; Biggs J; Drake E; Yetisir E; Hart RG
    JAMA; 1999 Aug; 282(8):737-43. PubMed ID: 10463708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients: insights from a specialist atrial fibrillation clinic.
    Lee SI; Sayers M; Lip GY; Lane DA
    Int J Clin Pract; 2015 Nov; 69(11):1341-8. PubMed ID: 26234557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing an Atrial Fibrillation Guideline Support Tool (AFGuST) for shared decision making.
    Eckman MH; Wise RE; Naylor K; Arduser L; Lip GY; Kissela B; Flaherty M; Kleindorfer D; Khan F; Schauer DP; Kues J; Costea A
    Curr Med Res Opin; 2015 Apr; 31(4):603-14. PubMed ID: 25690491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managing antithrombotic therapy in patients with both atrial fibrillation and coronary heart disease.
    Thompson PL; Verheugt FW
    Clin Ther; 2014 Sep; 36(9):1176-81. PubMed ID: 25234549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilization of antithrombotic therapy for stroke prevention in atrial fibrillation: a cross-sectional baseline analysis in general practice.
    Bajorek B; Magin PJ; Hilmer S; Krass I
    J Clin Pharm Ther; 2016 Aug; 41(4):432-40. PubMed ID: 27338004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Values and preferences in oral anticoagulation in patients with atrial fibrillation, physicians' and patients' perspectives: protocol for a two-phase study.
    Alonso-Coello P; Montori VM; Solà I; Schünemann HJ; Devereaux P; Charles C; Roura M; Díaz MG; Souto JC; Alonso R; Oliver S; Ruiz R; Coll-Vinent B; Diez AI; Gich I; Guyatt G
    BMC Health Serv Res; 2008 Oct; 8():221. PubMed ID: 18954427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Singer DE; Albers GW; Dalen JE; Fang MC; Go AS; Halperin JL; Lip GYH; Manning WJ
    Chest; 2008 Jun; 133(6 Suppl):546S-592S. PubMed ID: 18574273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of emerging antithrombotic therapy in the prevention of cardioembolic complications in patients with atrial fibrillation.
    Deedwania PC; Huang GW
    Am J Cardiovasc Drugs; 2011 Aug; 11(4):265-75. PubMed ID: 21740079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.